Non-Hodgkin's lymphoma is only infrequently restricted to a single anatomical area, but when it is, radiation therapy can result in a significant proportion of cures. More widespread disease requires systemic therapy. Most encouraging results are found with whole-body radiation used as a systemic ...
Non-Hodgkin's lymphoma (NHL) is cancer of the lymphatic system, a vital part of the body's immune system. Symptoms include swollen lymph nodes, fever, night sweats, coughing, weakness, chest pain, unexplained weight loss, and abdominal pain. Non-Hodgkin's lymphoma is a type of cancer th...
There are various methods to treat of Non-Hodgkin lymphoma. Once the condition has been diagnosed then the team of doctors decides the way of treatment based on the stage and location of cancer. If the Non-Hodgkin lymphoma is detected on early stage then, it is easy to treat the condition...
REVIEW Rituximab in the treatment of non-Hodgkin's lymphoma Beate Hauptrock Georg Hess Hematology/Oncology, Johannes Gutenberg-University, Mainz, Germany Abstract: Besides traditional cytostatic drugs the introduction of monoclonal antibodies has substantially influenced current treatment concepts of non-...
LymphomaPrednisoneCyclophosphamideVincristineDrug Therapy, CombinationCerny T, Gillessen S.doi:10.1093/annonc/mdf662T CernyS GillessenAnnals of OncologyCerny T, Gillessen S. Advances in the treatment of non-Hodgkin's lymphoma. Ann Oncol 2002;13:211-6....
Non-Hodgkin lymphomais a group of cancers of the lymphatic system that may arise in B or T cells of the immune system. Approximately 40% of non-Hodgkin lymphoma is known as diffuse large B-cell lymphoma, or DLBCL. Despite it being a more common subtype of non-Hodgkin lymphoma, DLB...
The authors report the development of osteosarcoma as a second neoplasia in a child with A-T who was treated, without being irradiated, for non-Hodgkin's lymphoma as a primary malignancy. This is the first report of osteosarcoma associated with A-T. The authors postulate that the mechanisms ...
Combination therapy of targeting CD20 antibody and immune checkpoint inhibitor may be a breakthrough in the treatment of B-cell lymphoma Hotspots in this field still focus on the efficacy of rituximab in treating non-Hodgkin's lymphoma and the pathogenesis of lymphoma Application of ... X Wu,X...
Background: Pemphigus foliaceus (PF), an autoimmune skin disorder resulting in the formation of superficial blisters, is a rarely reported skin manifestation of non‐Hodgkin's lymphoma (NHL). Typical therapies for PF in non‐malignant cases include immunosuppressants such as corticosteroids. We ...
A further aspect of the present invention relates to a combination of lilotomab and 177Lu-lilotomab satetraxetan for use in the treatment of Non-Hodgkin lymphoma wherein lilotomab and 177Lu-lilotomab satetraxetan is administered according to an administration pattern comprising predosing of 20-...